Zim Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on Jun 27, 2025
ZIMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zim Laboratories held its 41st AGM on June 27, 2025 via video conferencing from 11:30 AM to 12:53 PM, with 58 members participating. All 8 directors, including Chairman & MD Dr. Anwar Siraj Daud, were present along with the CFO, Company Secretary, and representatives of the auditors. The Statutory Auditors and Secretarial Auditors reported no qualifications or adverse remarks. Eight resolutions were placed before shareholders for e-voting, including adoption of FY25 audited financial statements, reappointment of a retiring director, appointment of Deloitte Haskins & Sells LLP as the new Statutory Auditor (replacing Walker Chandiok & Co.), appointment of BNP & Associates as Secretarial Auditor, reappointment/appointment of Independent Directors, and approval of remuneration for Independent Directors. The Chairman addressed shareholders on the company's overall performance for FY25.
This is a routine AGM disclosure, with no negative surprises from auditors. The most notable item is the auditor change to Deloitte, a Big 4 firm, which may be viewed positively as a sign of governance upgrade. E-voting results are awaited and will be filed separately, which could be the next material trigger for the stock.